Apr 22 |
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
|
Apr 22 |
NovaBay Pharmaceuticals receives NYSE notice for compliance
|
Apr 19 |
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
|
Apr 17 |
NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report
|
Apr 17 |
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
|
Mar 27 |
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2023 Earnings Call Transcript
|
Mar 27 |
Q4 2023 NovaBay Pharmaceuticals Inc Earnings Call
|
Mar 26 |
NovaBay Pharmaceuticals: Q4 Earnings Insights
|
Mar 13 |
NovaBay Pharmaceuticals and Eyenovia to Co-Promote Prescription Ophthalmic Products to U.S. Eyecare Professionals
|
Jan 30 |
NovaBay Pharmaceuticals posts 64% rise in 2023 Avenova unit subscription-based sales
|